Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

110
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
110

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Control of synaptic communication through molecularly engineered bioluminescence light emission and sensing.

Communications biology·2026
Same author

Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study.

Journal of hematology & oncology·2026
Same author

Proteomics reveal PTEN as a critical mediator of sustained mitochondrial dysfunction during chronic spinal cord injury.

Experimental neurology·2026
Same author

Correction: A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid‑binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.

Histochemistry and cell biology·2026
Same author

A bioluminescent activity dependent platform, BLADe, for converting intracellular activity to photoreceptor activation.

Scientific reports·2026
Same author

Etanercept in Spinal Cord Injury: A Systematic Review.

Brain sciences·2026

Related Experiment Video

Updated: May 5, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

9.5K

Presymptomatic targeted circuit manipulation for ameliorating Huntington's disease pathogenesis.

Ebenezer C Ikefuama1, Ashley N Slaviero2, Alexander D Silvagnoli1

  • 1Program in Neuroscience, Central Michigan University, Mount Pleasant, MI 48859, USA.

Iscience
|March 17, 2025
PubMed
Summary

Targeting early Huntington's disease (HD) by adjusting brain circuit activity before symptom onset can slow disease progression. Modulating specific neuron types in the motor cortex improved motor function in a mouse model, offering a potential therapeutic strategy.

Keywords:
Cellular neuroscienceMolecular neuroscience

More Related Videos

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

7.9K
Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

6.1K

Related Experiment Videos

Last Updated: May 5, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

9.5K
Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

7.9K
Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

6.1K

Area of Science:

  • Neuroscience
  • Neurodegenerative Disorders
  • Molecular Biology

Background:

  • Huntington's disease (HD) involves excitatory/inhibitory (E/I) imbalance in brain circuits before motor and cognitive symptoms appear.
  • This pre-symptomatic window offers a critical opportunity for therapeutic intervention to restore E/I balance and slow disease progression.

Purpose of the Study:

  • To investigate the impact of cell-type specific modulation of M1 motor cortex activity on disease progression in a pre-symptomatic HD mouse model.
  • To determine if dampening pyramidal neuron excitation or increasing interneuron activity can alleviate early HD-related deficits.

Main Methods:

  • Utilized the R6/2 mouse model of Huntington's disease.
  • Administered daily, cell-type specific manipulations of pyramidal neurons (Emx1) and parvalbumin interneurons in the M1 motor cortex for three weeks during the pre-symptomatic phase.
  • Assessed effects on motor coordination and disease progression.

Main Results:

  • Dampening Emx1 pyramidal neuron excitation significantly alleviated HD-related motor coordination dysfunction.
  • Increasing parvalbumin interneuron activity also ameliorated motor deficits in the pre-symptomatic HD mouse model.
  • These findings demonstrate that normalizing cortical output via cell-type specific modulation is effective in an HD model.

Conclusions:

  • Cell-type specific modulation of cortical microcircuits represents a promising therapeutic strategy for Huntington's disease.
  • Targeting E/I balance in the pre-symptomatic phase can prevent or slow the progression of motor deficits in HD.
  • This approach may also be applicable to other neurodegenerative disorders characterized by circuit dysfunction.